Article Text

Download PDFPDF
Impact of offspring and their educational level on readmission and death among older adults with chronic obstructive pulmonary disease: a nationwide cohort study using multistate survival models
  1. Mathilde Marie Brünnich Sloth1,2,
  2. Emma Neble Larsen1,2,
  3. Nina Skavlan Godtfredsen3,4,
  4. Merete Osler2,5,
  5. Terese Sara Høj Jørgensen1,2
  1. 1 Section of Social Medicine, Department of Public Health, University of Copenhagen, Copenhagen, Denmark
  2. 2 Center for Clinical Research and Prevention, Copenhagen University Hospital, Frederiksberg, Denmark
  3. 3 Department of Respiratory Diseases, Hvidovre Hospital, Hvidovre, Denmark
  4. 4 Institute of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark
  5. 5 Section of Epidemiology, Department of Public Health, University of Copenhagen, Copenhagen, Denmark
  1. Correspondence to Mathilde Marie Brünnich Sloth, Section of Social Medicine, University of Copenhagen Department of Public Health, Kobenhavn 1150, Denmark; mathildemarie{at}me.com

Abstract

Background It is well described that there is social inequality in the disease course of chronic obstructive pulmonary disease (COPD), but the impact of social relations is less explored. We aimed to investigate the impact of adult offspring and their educational level on readmission and death among older adults with COPD.

Methods In total, 71 084 older adults born 1935–53 with COPD diagnosed at age ≥65 years in 2000–2018 were included. Multistate survival models were performed to estimate the impact of adult offspring (offspring (reference) vs no offspring) and their educational level (low, medium or high (reference)) on the transition intensities between three states: COPD diagnosis, readmission and all-cause death.

Results During follow-up, 29 828 (42.0%) had a readmission and 18 504 (26.0%) died with or without readmission. Not having offspring was associated with higher hazards of death without readmission (HRwomen: 1.52 (95% CI: 1.39 to 1.67), HRmen: 1.29 (95% CI: 1.20 to 1.39)) and a higher hazard of death after readmission for women only (HRwomen: 1.19 (95% CI: 1.08 to 1.30). Having offspring with low educational level was associated with higher hazards of readmission (HRwomen: 1.12 (95% CI: 1.06 to 1.19)), (HRmen: 1.06 (95%CI: 1.002 to 1.12)), death without readmission (HRwomen: 1.24 (95% CI: 1.11 to 1.39)), HRmen: 1.16 (95% CI: 1.05 to 1.29) and death after readmission for men only (HRmen: 1.15 (95% CI: 1.05 to 1.25)). Having offspring with medium educational level was associated with a higher hazard of death without readmission for women (HRwomen: 1.11 (95% CI: 1.02 to 1.21)).

Conclusion Adult offspring and their educational level were associated with higher risk of readmission and death among older adults with COPD.

  • SOCIAL CAPITAL
  • COHORT STUDIES
  • EPIDEMIOLOGY
  • GERONTOLOGY
  • HEALTHCARE DISPARITIES

Data availability statement

Data may be obtained from a third party and are not publicly available. In this study we have used data from Statistics Denmark. To access the anonymised dataset used in this study, researchers need to apply to Statistics Denmark. Only aggregated data, where no identification of persons is possible i.e. minimum five observations in each cell, can be removed from the server containing the data accessed through Statistics Denmark. Thus, we cannot provide an anonymised copy of the dataset as individuals may be identified based on the information in the data. Access to the data through Statistics Denmark is only granted for authorised research and analysis environments of a more permanent nature with a chief researcher and several researchers/analysts. Foreign researchers affiliated to a Danish authorised environment can also get access. Authorisation is granted by the Director General. Please find more information in the document 'Access to micro data at Statistics Denmark_2014' on https://www.dst.dk/en/TilSalg/Forskningsservice.

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Data availability statement

Data may be obtained from a third party and are not publicly available. In this study we have used data from Statistics Denmark. To access the anonymised dataset used in this study, researchers need to apply to Statistics Denmark. Only aggregated data, where no identification of persons is possible i.e. minimum five observations in each cell, can be removed from the server containing the data accessed through Statistics Denmark. Thus, we cannot provide an anonymised copy of the dataset as individuals may be identified based on the information in the data. Access to the data through Statistics Denmark is only granted for authorised research and analysis environments of a more permanent nature with a chief researcher and several researchers/analysts. Foreign researchers affiliated to a Danish authorised environment can also get access. Authorisation is granted by the Director General. Please find more information in the document 'Access to micro data at Statistics Denmark_2014' on https://www.dst.dk/en/TilSalg/Forskningsservice.

View Full Text

Footnotes

  • Twitter @mathilde_sloth, @EmmaNebleLarsen, @TereseHoej

  • Contributors All authors have approved the final article. TSHJ, MMBS and ENL have full access to all of the data in the study and take responsibility for the integrity of the data and the accuracy of the data analyses. Study concept: TSHJ, MO, MMBS and ENL. Study design: TSHJ, NSG, MO, MMBS and ENL. Acquisition of data: TSHJ. Statistical analysis: MMBS. Interpretation of results: all authors. Drafting of the manuscript: MMBS. Critical revision of the manuscript for important intellectual content: all authors. Guarantor: MMBS.

  • Funding TSHJ, MMBS and ENL were supported by Helsefonden (grant no 18-B-0026) and the Danish Heart Foundation (no A8374).

  • Competing interests None declared.

  • Provenance and peer review Not commissioned; externally peer reviewed.

  • Supplemental material This content has been supplied by the author(s). It has not been vetted by BMJ Publishing Group Limited (BMJ) and may not have been peer-reviewed. Any opinions or recommendations discussed are solely those of the author(s) and are not endorsed by BMJ. BMJ disclaims all liability and responsibility arising from any reliance placed on the content. Where the content includes any translated material, BMJ does not warrant the accuracy and reliability of the translations (including but not limited to local regulations, clinical guidelines, terminology, drug names and drug dosages), and is not responsible for any error and/or omissions arising from translation and adaptation or otherwise.